Clinical Trial Update: Beneficial Effect of Intravenous Magnesium Sulphate in Term Neonates With Hypoxic Ischemic Encephalopathy(HIE) [Phase 2]

View source ↗

Summary

Phase 2 trial reporting beneficial effect of intravenous magnesium sulfate in term neonates with hypoxic-ischemic encephalopathy (HIE).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypoxic-ischemic Encephalopathy

Drugs mentioned

• Magnesium sulfate (magnesium sulfate)

Snippet

Sponsor: Services Institute of Medical Sciences, Pakistan | Conditions: HIE | Phase 2 | Status: COMPLETED